Stopping douching products after menstruation may reduce risk of bacterial vaginosis.
Women who regularly use douching products to cleanse the vagina after menstruation may reduce the risk of bacterial vaginosis (BV) by stopping the practice, according to research published in the June issue of the American Journal of Obstetrics and Gynecology.
Rebecca M. Brotman, PhD, of Johns Hopkins Bayview Medical Center in Baltimore, and colleagues conducted a study of 39 women who reported using douching products. The women used the products for 4 weeks, then stopped for a 12-week observation period, after which they decided whether to resume douching or continue cessation for the final 4 weeks of the study. Twice-weekly self-collected vaginal samples were taken and a final sample was collected during the last week.
During the douching cessation phase, the odds of developing BV was 0.76 compared with the odds during the initial douching stage, the investigators found. For women who had reported douching to cleanse the vagina after menstruation, cessation significantly reduced the risk of BV (adjusted odds ratio, 0.23).
Brotman RM, Ghanem KG, Klebanoff MA, et al. The effect of vaginal douching cessation on bacterial vaginosis: a pilot study. Am J Obstet Gynecol. 2008;198:628.e1-628.e7.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More